Quantification of testosterone and metabolites released after alkaline treatment in human urine
- 1 November 2010
- journal article
- research article
- Published by Wiley in Drug Testing and Analysis
- Vol. 2 (11-12) , 630-636
Abstract
A rapid, accurate, and sensitive method based on liquid chromatography‐tandem mass spectrometry (LC‐MS/MS) for the quantification of the testosterone (T) fraction released under basic conditions and its metabolites 1,4‐androstadien‐3,17‐dione (1,4‐AD), 4,6‐androstadien‐3,17‐dione (4,6‐AD) and 4,6‐androstadien‐17β‐ol‐3‐one (6‐T) obtained in the same way has been developed and validated. Urine samples (5 ml) were alkalinized and the released analytes were extracted by liquid‐liquid extraction. The chromatographic separation was performed in 8 min. MS/MS determination was performed under selected reaction monitoring mode using electrospray ionization in positive mode. The method was shown to be linear from 0.05 to 50 ng/ml for 1,4‐AD, 6‐T and T while for 4,6‐AD the linearity from 0.5 to 500 ng/ml was demonstrated (r > 0.99). Limits of detection below 0.05 ng/ml were obtained for all analytes. Intra‐assay precision and accuracies, evaluated at three concentrations levels (0.1, 1 and 20 ng/ml) were below 20%. The applicability of the analytical method was confirmed by analysis of several samples collected from healthy volunteers and samples collected after oral testosterone undecanoate administration. The analytical method was found to be able to quantify the metabolites either at the low concentrations levels present in the urine from untreated volunteers or at the high concentrations found after T administration. Short analysis time, simple sample preparation, and satisfactory quantitative parameters make this method potentially useful for anti‐doping control purposes. Copyright © 2010 John Wiley & Sons, Ltd.Keywords
This publication has 13 references indexed in Scilit:
- Testosterone metabolism revisited: discovery of new metabolitesAnalytical and Bioanalytical Chemistry, 2010
- Detection and Characterization of a New Metabolite of 17α-MethyltestosteroneDrug Metabolism and Disposition, 2009
- Detection and structural investigation of metabolites of stanozolol in human urine by liquid chromatography tandem mass spectrometrySteroids, 2009
- Testosterone Doping: Dealing with Genetic Differences in Metabolism and ExcretionThe Journal of Clinical Endocrinology & Metabolism, 2008
- Liquid chromatographic–mass spectrometric analysis of glucuronide‐conjugated anabolic steroid metabolites: method validation and interlaboratory comparisonJournal of Mass Spectrometry, 2008
- Direct quantification of steroid glucuronides in human urine by liquid chromatography–electrospray tandem mass spectrometryJournal of Chromatography A, 2008
- Mass spectrometric identification and characterization of a new long‐term metabolite of metandienone in human urineRapid Communications in Mass Spectrometry, 2006
- Plasma and urinary markers of oral testosterone undecanoate misuseSteroids, 2002
- The Effects of Supraphysiologic Doses of Testosterone on Muscle Size and Strength in Normal MenNew England Journal of Medicine, 1996
- Urinary Excretion of Testosterone and Epitestosterone and Plasma Levels of LH and Testosterone in the Japanese and AinuThe Journal of Clinical Endocrinology & Metabolism, 1971